BioAssay Systems

San Francisco, United States Founded: 2003 • Age: 23 yrs Acquired By VION Biosciences
Biochemical assay development for drug discovery and research

About BioAssay Systems

BioAssay Systems is a company based in San Francisco (United States) founded in 2003 was acquired by VION Biosciences in February 2025. The company has 14 employees. BioAssay Systems offers products and services including Assay Kits, Analytical Services, and Inhibitor HTS Kits. BioAssay Systems operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.

  • Headquarter San Francisco, United States
  • Employees 14
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website bioassaysys.com
  • Social LinkedIn X Facebook
  • Acquired by VION Biosciences (Feb 2025)
  • Legal Name Bioassay Systems, Llc
Key Metrics

Products & Services of BioAssay Systems

BioAssay Systems offers a comprehensive portfolio of products and services, including Assay Kits, Analytical Services, and Inhibitor HTS Kits.

Assay Kits
Biochemical Testing

Kits for measuring enzyme activity and biological markers in research

Analytical Services
Research Support

Custom assay development and analysis for scientific applications

Inhibitor HTS Kits
High-Throughput Screening

Kits for testing inhibitors in drug discovery processes

Investors in BioAssay Systems

BioAssay Systems has secured backing from 1 investor. Prominent investors backing the company include VION Biosciences.

All
InvestorDescriptionFounded YearDomainLocation
Provides end-to-end solutions for drug development, diagnostics, and research manufacturing.
2023vionbiosciences.comCharlottesville, United States
Premium access

Investor details for BioAssay Systems

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of BioAssay Systems

2 dated milestones of BioAssay Systems across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioAssay Systems is founded.
  2. Exit Acquired by VION Biosciences.

Competitors of BioAssay Systems

BioAssay Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
abcam.com1998Cambridge, United Kingdom$78.8M405
Biological reagents and antibodies are developed for life science research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
stemcell.com1993Vancouver, Canada$11.92M129
Developer of cell culture media and ancillary reagents for life science research
miltenyibiotec.com1989Bergisch Gladbach, Germany–585
Develops tools and products for research and clinical application
devyser.com2004Stockholm, Sweden$15.48M–
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
teknova.com1996Hollister, United States–290
Molecular biology reagents and kits are supplied for research applications.
meridianbioscience.com1976Ohio, United States––
Molecular diagnostic device and kits
bbisolutions.com1986Crumlin, United Kingdom–301
Kits and reagents are developed for life science research applications.
Premium access

Detailed competitors of BioAssay Systems

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioAssay Systems

The website of BioAssay Systems (bioassaysys.com) receives about 12.4K visits a month.

  • Monthly visits
    12.4K

    ▲ 1.1% vs previous month

Similar websites

Websites whose visitors overlap most with BioAssay Systems. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
oxfordbiomed.com
100%
3.8K#4,977,915View details
bmrservice.com
bmrservice.com
91%
–––
caymanchem.com
89%
393.1K#148,469View details
biovision.com
87%
––View details
cellbiolabs.com
86%
38.9K#876,566View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 22 similar websites and full traffic analytics for BioAssay Systems

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 22 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Bioassay Systems

VION Biosciences’ Acquisition of BioAssay Systems
Globallegalchronicle β€’ 1 year ago
Premium access

Complete news archive for BioAssay Systems

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to BioAssay Systems

10 companies that operate in the same segment as BioAssay Systems (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioAssay Systems

BioAssay Systems was founded in 2003.

BioAssay Systems is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

BioAssay Systems has 14 employees.

BioAssay Systems develops and markets kits and reagents for biochemical and molecular assays for life sciences research. The companys focus is on non-radioactive assay formats such as fluorescence, absorbance, and luminescence-based detection, and it has a range of off-the-shelf assays for blood and urine chemistry, ion detection, and measurement, high-throughput screening, metabolic, stress and signal transduction assays. In addition to their catalog assays, the company also offers assay development, optimization, and customization as a service along with lead discovery services for pharma clients. BioAssay Systems also manufactures hand-held fluorimeters, cell analyzers, and microplates.

BioAssay Systems's top competitors include Abcam, Sino Biological and Meridian Bioscience.

BioAssay Systems offers Assay Kits, Analytical Services, and Inhibitor HTS Kits.

BioAssay Systems has 1 investor. Key investors include VION Biosciences.

BioAssay Systems operates through Bioassay Systems, Llc.

Yes. BioAssay Systems was acquired by VION Biosciences in February 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available